AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Revenue by Segment

Financials in millions JPY. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016
Catering Business	2.41B	2.18B	1.48B	920.51M	157.55M
Department Store Business	4.62B	4.95B	5.20B	4.70B	3.21B
Healthcare Business	19.04B	18.20B	15.25B	15.14B	17.43B
Others Business	1.66B	772.27M	1.56B	463.82M	-
Pharmaceuticals Business	2.48B	2.31B	2.09B	1.78B	1.57B
Real Estate Trust Business	2.71B	1.95B	-	-	-
Unallocated Adjustment	-275.22M	-178.08M	-	-	-
Total	32.66B	30.19B	25.58B	23.00B	22.37B

Revenue by Geography

Financials in millions JPY. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016
Japan	28.03B	26.35B	23.57B	20.48B	17.48B
Asia (Excluding Japan)	4.62B	3.83B	1.99B	2.37B	-
Others	7.66M	6.33M	13.98M	150.88M	1.06B
Indonesia	-	-	-	-	3.83B
Total	32.66B	30.19B	25.58B	23.00B	22.37B

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error